Profile data is unavailable for this security.
About the company
Zhaoke Ophthalmology Ltd is a China-based investment holding company principally engaged in the development, manufacturing and marketing of ophthalmic drugs. The Company’s products include innovative drugs and generic drugs. The Company ‘s products are mainly applied in five ophthalmic indications, including dry eye disease (DED), wet age-related macular degeneration (wAMD), diabetic macular edema (DME), myopia and glaucoma.
- Revenue in HKD (TTM)20.14m
- Net income in HKD-413.60m
- Incorporated2020
- Employees313.00
- LocationZhaoke Ophthalmology LtdNo. 1 Meide 3rd Road, Pearl RiverIndustrial Park, Nansha DistrictGUANGZHOU ChinaCHN
- Phone+86 2 039062888
- Websitehttps://www.zkoph.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wai Yuen Tong Medicine Holdings Limited | 783.88m | -26.68m | 393.79m | 1.96k | -- | 0.2955 | 4.81 | 0.5024 | -0.0228 | -0.0132 | 0.6636 | 1.18 | 0.1721 | 0.4001 | 10.55 | -- | -0.1597 | -0.3053 | -0.2538 | -0.5206 | 50.37 | 43.82 | -0.928 | -2.18 | 1.37 | 1.24 | 0.2497 | -- | 8.33 | 0.8488 | -62.16 | -- | -- | -- |
| Tianda Pharmaceuticals Ltd | 532.09m | -24.16m | 569.76m | 863.00 | -- | 0.9623 | 49.97 | 1.07 | -0.0112 | -0.0112 | 0.2475 | 0.2754 | 0.5306 | 4.88 | 4.37 | 616,557.40 | -2.49 | -- | -3.84 | -- | 48.02 | -- | -4.70 | -- | 0.8907 | -13.98 | 0.161 | -- | -- | -- | -- | -- | -- | -- |
| Transcenta Holding Limited | 57.84m | -496.88m | 619.32m | 215.00 | -- | 0.5599 | -- | 10.71 | -1.22 | -1.22 | 0.1421 | 2.54 | 0.0281 | 2.05 | 1.49 | 269,037.00 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -32.87 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 671.27m | 1.06k | 40.20 | 0.3292 | 4.30 | 0.6375 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 903.96m | 159.20m | 728.33m | 848.00 | 4.57 | 0.458 | 5.97 | 0.8057 | 0.2842 | 0.2842 | 1.61 | 2.84 | 0.3587 | 2.18 | 2.94 | 1,065,993.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Pak Fah Yeow International Ltd | 259.16m | 105.04m | 747.94m | 102.00 | 7.12 | 0.9775 | 6.65 | 2.89 | 0.337 | 0.337 | 0.8316 | 2.46 | 0.2995 | 2.88 | 22.18 | 2,540,765.00 | 12.14 | 3.99 | 12.60 | 4.18 | 84.45 | 80.79 | 40.53 | 21.27 | 6.90 | 10.08 | 0.0062 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Fusen Pharmaceutical Co Ltd | 607.56m | -38.97m | 757.46m | 1.15k | -- | 1.25 | -- | 1.25 | -0.0522 | -0.0522 | 0.8079 | 0.8071 | 0.4199 | 1.95 | 8.36 | 529,232.40 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Zhaoke Ophthalmology Ltd | 20.14m | -413.60m | 770.06m | 313.00 | -- | 0.35 | -- | 38.23 | -0.7604 | -0.7604 | 0.037 | 4.03 | 0.0075 | -- | 0.531 | 64,347.21 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 825.47m | 279.00 | 6.69 | 0.8478 | 4.49 | 1.27 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.20bn | 174.85m | 993.14m | 2.64k | 5.57 | 0.8818 | 3.47 | 0.451 | 0.2064 | 0.2064 | 2.60 | 1.30 | 1.12 | 2.53 | 10.54 | 833,085.60 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Ascletis Pharma Inc | 60.79m | -155.45m | 1.05bn | 219.00 | -- | 0.431 | -- | 17.33 | -0.1461 | -0.1461 | 0.0566 | 2.41 | 0.022 | 2.30 | 3.86 | 277,596.80 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| VIVA Biotech Holdings | 2.32bn | -124.73m | 1.08bn | 2.08k | -- | 0.2703 | 9.03 | 0.4667 | -0.0634 | -0.0634 | 1.19 | 1.85 | 0.2805 | 4.84 | 5.21 | 1,114,808.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Hbm Holdings Ltd | 698.80m | 177.99m | 1.13bn | 177.00 | 6.07 | 1.15 | 5.28 | 1.62 | 0.2421 | 0.2421 | 0.9521 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,947,999.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
Data as of Jul 19 2024. Currency figures normalised to Zhaoke Ophthalmology Ltd's reporting currency: Hong Kong Dollar HKD
7.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 2024 | 35.78m | 6.55% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.00m | 0.18% |
| Janus Henderson Investors US LLCas of 31 May 2024 | 701.00k | 0.13% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 525.50k | 0.10% |
| Amundi (UK) Ltd.as of 31 May 2024 | 331.50k | 0.06% |
| SSgA Funds Management, Inc.as of 03 Jul 2024 | 220.88k | 0.04% |
| Amundi Hong Kong Ltd.as of 30 Jun 2023 | 63.50k | 0.01% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 47.00k | 0.01% |
| Janus Henderson Investors UK Ltd.as of 31 May 2024 | 0.00 | 0.00% |
| Janus Henderson Investors (Australia) Inst. Funds Mgmt. Ltd.as of 31 May 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
